IP Library Granted Patent US 10,316,358
Granted Patent B2
US 10,316,358 · App. 15/247,728 · Granted Jun 11, 2019

Oscillating amplification reaction for nucleic acids

Inventors: Hong Cai (Los Alamos, NM); Nathan J. Cobb (Santa Fe, NM)
Assignee: Mesa Biotech, Inc.
C12Q1/686C12P19/34C12Q1/6844
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,316,358
App. No.
15/247,728
Granted
Jun 11, 2019
Kind
B2
Abstract

One embodiment of the present invention provides for a method for amplifying a template of nucleic acid target sequence contained in a sample. The method includes contacting the sample with an amplification reaction mixture containing a primer complementary to the template of nucleic acid target sequence. A temperature of the reaction is oscillated between an upper temperature and a lower temperature wherein the change in temperature is no greater than about 20° C. during a plurality of temperature cycles. The template of nucleic acid target sequence is amplified.

Claims (50)

1. A method for amplifying a target nucleic acid sequence contained in a sample, the method comprising:

contacting the sample with an amplification reaction mixture comprising a primer complementary to the target nucleic acid sequence;

oscillating a temperature of the reaction between an upper temperature and a lower temperature wherein a change in temperature is no greater than 20° C. during a plurality of temperature cycles; and

amplifying the target nucleic acid sequence.

2. The method of claim 1 wherein the change in temperature is no greater than about 15° C. during a plurality of temperature cycles.

3. The method of claim 1 wherein the change in temperature is no greater than about 10° C. during a plurality of temperature cycles.

4. The method of claim 1 wherein the change in temperature is no greater than about 5° C. during a plurality of temperature cycles.

5. The method of claim 1 wherein upon reaching the upper temperature or the lower temperature, the temperature is maintained for a set period of time within a temperature fluctuation.

6. The method of claim 1 wherein upon reaching an upper or lower temperature within the temperature range, the temperature is varied to the other temperature.

7. The method of claim 1 wherein the lower temperature is no less than about 50° C.

8. The method of claim 1 wherein the upper temperature is no greater than about 85° C.

9. The method of claim 1 wherein the target nucleic acid sequence comprises single stranded DNA or RNA.

10. The method of claim 1 wherein the target nucleic acid sequence comprises double stranded DNA or RNA.

11. The method of claim 1 wherein the target nucleic acid sequence is RNA.

12. The method of claim 1 wherein the target nucleic acid sequence is DNA.

13. The method of claim 1 wherein the length of the target nucleic acid sequence is less than about 1000 bp.

14. The method of claim 1 wherein the length of the target nucleic acid sequence is less than about 250 bp.

15. The method of claim 1 wherein the length of the target nucleic acid sequence is less than about 150 bp.

16. The method of claim 1 wherein the length of the target nucleic acid sequence is be less than about 100 bp.

17. The method of claim 1 wherein the amplification reaction mixture comprises a pair of primers which bind to opposite strands of the target nucleic acid sequence.

18. The method of claim 17 wherein the each primer of the primer pair has a length and a GC content so that its melting temperature is 65° C.

19. The method of claim 18 wherein the each primer of the primer pair has a length and a GC content so that the melting temperature is ≥70°.

20. The method of claim 19 wherein the melting temperature of each primer of the primer pair is between 70-80° C.

21. The method of claim 17 wherein the each primer of the primer pair has a length of 35-70 base pairs.

22. The method of claim 17 wherein the pair of primers comprise a forward primer and a reverse primer each having a length of 40-47 base pairs.

23. The method of claim 1 wherein the amplification reaction mixture comprises a nucleic acid destabilizing agent.

24. The method of claim 23 wherein the destabilizing agent is selected from the group consisting of dimethylsulfoxide (DMSO), formamide, Betaine, and combinations thereof.

25. The method of claim 23 wherein a concentration of the nucleic acid destabilizer is from 8-15 volume percent.

26. The method of claim 23 wherein the destabilizing agent is a single strand or double strand nucleic acid destabilizing agent.

27. The method of claim 1 wherein the amplification reaction mixture comprises a DNA polymerase.

28. The method of claim 27 wherein the DNA polymerase is buffered at a pH to support activity.

29. The method of claim 27 wherein the DNA polymerase is a thermostable DNA polymerase.

30. The method of claim 27 wherein the DNA polymerase is selected from the group consisting of TAQ DNA polymerase, VentR DNA polymerase, and DeepVentR DNA polymerase.

31. The method of claim 27 wherein the DNA polymerase comprises a strand displacing activity.

32. The method of claim 27 wherein the DNA polymerase does not have 3′→5′ exonuclease activity.

33. The method of claim 1 wherein the amplification reaction mixture comprises a reverse transcriptase.

34. The method of claim 33 wherein the reverse transcriptase is a thermostable reverse transcriptase.

35. The method of claim 33 wherein the reverse transcriptase is selected from AMV-RT, Superscript II reverse transcriptase, Superscript III reverse transcriptase, or MMLV-RT.

36. The method of claim 1 wherein the amplification reaction mixture comprises a single stranded binding protein.

37. The method of claim 36 wherein the single stranded binding protein is a thermal stable single stranded binding protein.

38. The method of claim 36 wherein the single stranded binding protein is a non-thermal stable single stranded binding protein.

39. The method of claim 1 wherein the sample is not alcohol free.

40. The method of claim 1 wherein the sample is not salt free.

41. The method of claim 1 wherein the upper temperature is a denaturation temperature and a lower temperature is an annealing temperature.

42. The method of claim 41 wherein the upper denaturation temperature is sufficiently high to completely denature the target nucleic acid sequence.

43. The method of claim 1 further comprising mixing a solution comprising a divalent cation together with other components to form the amplification reaction mixture.

44. The method of claim 43 wherein the solution is a buffer.

45. The method of claim 43 wherein the divalent cation is a salt comprising an element selected from the group consisting of magnesium, manganese, copper, zinc and any combination thereof.

46. The method of claim 43 wherein the solution comprises a monovalent cation.

47. The method of claim 46 wherein the monovalent cation is a salt comprising an element selected from the group consisting of sodium, potassium, lithium, rubidium, cesium, ammonium and any combination thereof.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR AND ASSIGNEE NAMES WHICH WERE INADVERTENTLY TRANSPOSED PREVIOUSLY RECORDED AT REEL: 054938 FRAME: 0782. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 22, 2021
From: YONGHUA INTERNATIONAL I L.P.; YH NORTH AMERICA CAPITAL LIMITED
To: MESA BIOTECH, INC.
Reel/Frame 055086/0777 →
RELEASE OF SECURITY INTEREST Recorded Jan 15, 2021
From: YONGHUA INTERNATIONAL I L.P.; YH NORTH AMERICA CAPITAL LIMITED
To: MESA BIOTECH, INC.; YH NORTH AMERICA CAPITAL LIMITED
Reel/Frame 054938/0782 →
RELEASE OF SECURITY INTEREST Recorded Dec 22, 2020
From: YONGHUA INTERNATIONAL I L.P.; YH NORTH AMERICA CAPITAL LIMITED
To: MESA BIOTECH, INC.
Reel/Frame 054836/0481 →
MERGER Recorded Aug 8, 2017
From: MESA TECH INTERNATIONAL, INC.
To: MESA BIOTECH, INC.
Reel/Frame 043231/0659 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 12, 2017
From: CAI, HONG; COBB, NATHAN J.
To: MESA TECH INTERNATIONAL, INC.
Reel/Frame 042990/0301 →
SECURITY INTEREST Recorded Jan 11, 2017
From: MESA BIOTECH, INC.
To: YONGHUA INTERNATIONAL I L.P.; YH NORTH AMERICA CAPITAL LIMITED
Reel/Frame 041328/0291 →
Continuity (4)
Continuation 14113200
Provisional Application 61477437 · Apr 20, 2011
Provisional Application 61477357 · Apr 20, 2011
Related Publication 20160362725A1 · Dec 15, 2016
Cited By (1)
US 12,421,543